Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Amyris Gains on Deal to Develop Microorganism for BASF

Amyris Inc., the biotechnology company partially owned by Total SA, rose after agreeing to develop a microorganism for BASF SE.

Amyris gained 4 percent to $4.19 at the close in New York, the most since April 1.

The company, based in Emeryville, California, will develop a microorganism that produces a “relevant target molecule” for BASF, according to a statement today. Amyris didn’t say what the molecule will do or provide terms of the deal.

The companies expect the agreement to lead to other joint efforts. Amyris uses genetically modified microorganisms to convert plant sugars into fragrance oils and farnesene, a hydrocarbon that may be processed into fuels or specialty chemicals.

Total, France’s largest oil producer, owns about 18 percent of the company, according to data compiled by Bloomberg.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.